Total Funding
57
74
Total FundingPost-IPO Debt raised
Growth Score 57 in past quarter
-6 pts
Heat Score 74 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
234464
ASIT biotech specializes in the research and development of immunotherapeutic products for allergy treatment.
- Marc Nolet de Brauwere: Co-founder and Co-Owner
- Desiront Yves: CFO
About the Company
ASIT biotech specializes in the research and development of immunotherapeutic products for allergy treatment.